C-di-GMP signaling and implications for pathogenesis of Mycobacterium tuberculosis by Tao Cui & ZhengGuo He
   
 
© The Author(s) 2012. This article is published with open access at Springerlink.com csb.scichina.com   www.springer.com/scp 
                          
*Corresponding author (email: he.zhengguo@hotmail.com, 
hezhengguo@mail.hzau.edu.cn) 
Review 
SPECIAL TOPICS:  
Progress of Projects Supported by NSFC December 2012  Vol.57  No.34: 43874393 
Microbiology doi: 10.1007/s11434-012-5298-5 
C-di-GMP signaling and implications for pathogenesis of  
Mycobacterium tuberculosis 
CUI Tao & HE ZhengGuo* 
National Key Laboratory of Agricultural Microbiology, Center for Proteomics Research, College of Life Science and Technology, Huazhong 
Agricultural University, Wuhan 430070, China 
Received April 26, 2012; accepted May 11, 2012; published online September 22, 2012 
 
C-di-GMP is a ubiquitous bacterial second messenger that regulates a wide range of bacterial physiological processes including 
biofilm formation, virulence, motility and cell differentiation. Here, we have summarized our current knowledge on the upstream 
signaling factors and downstream effectors of c-di-GMP in addition to the interaction between c-di-GMP and eukaryotic organ-
isms. New discoveries in these areas have enriched our understanding of the diversity of c-di-GMP signaling pathways and pro-
vide important clues for us to explore the roles of c-di-GMP signaling in human pathogens such as Mycobacterium tuberculosis. 
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Bis-(3ʹ-5ʹ)-cyclic dimeric guanosine monophosphate (c-di- 
GMP) (Figure 1) is a ubiquitous bacterial second messenger 
that regulates a wide range of complex cellular processes 
[1,2] including biofilm formation [3], virulence [4], motility 
[5,6] and differentiation [7], and contributes to the patho-
genesis of some types of bacteria. In most cases, a high level 
of intracellular c-di-GMP stimulates biofilm formation and 
cell cycle arrest while low c-di-GMP levels contribute to 
virulence, motility and cell division. Interestingly, although 
c-di-GMP is absent in eukaryotes, exogenous application of 
c-di-GMP can arrest cell cycle in eukaryotes [8,9] and stim-
ulate the immune system of higher organisms [10,11]. 
1  Metabolism of c-di-GMP 
The intracellular synthesis and degradation of c-di-GMP are 
mediated by diguanylate cyclase (DGC) and phos-
phodiesterase (PDE), respectively (Figure 2)[1,12]. The  
 
Figure 1  Structure of c-di-GMP. 
GGDEF domain of diguanylate cyclases produces a 
c-di-GMP molecule from two GTPs. The EAL and 
HD-GYP domains of phosphodiesterases on the other hand 
hydrolyze c-di-GMP into pGpG and two molecules of 
GMPs, respectively [13]. Although widespread in bacteria, 
the GGDEF, EAL and HD-GYP domains are absent in eu-
karyotes [13–15]. In addition, a newly identified protein 
called YybT in Bacillus subtilis, which contains a 
DHH/DHHA1 domain, can also hydrolyze c-di-GMP into 
pGpG [16]. Unlike the EAL domain, the DHH/DHHA1 
domain is a multi-functional phosphodiesterase and can also 
hydrolyze c-di-AMP, a second messenger involved in DNA 
damage response [17], into pApA [16]. 
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Figure 2  Synthesis and degradation of c-di-GMP. 
C-di-GMP signaling has been studied heavily in recent 
years. Here, we summarize the latest discoveries on 
c-di-GMP signaling, including various upstream signaling 
factors and a variety of downstream effectors, in addition to 
the interaction between c-di-GMP and eukaryotic organisms. 
The potential roles of c-di-GMP signaling in M. tuberculo-
sis are also discussed.  
2  Signals regulating intracellular c-di-GMP 
level 
Intracellular c-di-GMP levels are controlled by enzyme ac-
tivities of diguanylate cyclases and phosphodiesterase. The 
GGDEF domain has feedback regulation. Besides an “A” 
site with catalytic activity, the GGDEF domain contains an 
“I” site which can inhibit diguanylate cyclases when bound 
to c-di-GMP [18–20]. 
In addition, c-di-GMP synthesis and degradation by 
diguanylate cyclases and phosphodiesterases can be regu-
lated by various signals, such as phosphorylation [21,22], 
light [23] and nitric oxide [24]. The diversity in regulatory 
factors comes from the fact that GGDEF and EAL domains 
of diguanylate cyclases and phosphodiesterases, respective-
ly, can interact with numerous signal molecules or regula-
tory domains [14,15,25]. Such domains include REC [22], 
GAF [26], PAS [27], BLUF [23] and others. 
The response regulator PleD in Caulobacter crescentus 
contains an N-terminal phospho-receptor domain and a C- 
terminal GGDEF domain. Phosphorylation of the recevier 
domains causes the formation of dimers and activation of 
diguanylate cyclases [21]. BlrP1 of Klebsiella pneumoniae 
contains an N-terminal light-receptor BLUF domain and a 
C-terminal EAL domain. The BLUF domain senses blue 
light with FAD chromophore. BLUF can allosterically reg-
ulate the phosphodiesterase activity of EAL domains when 
stimulated by light [23]. 
Besides allosteric regulation, protein-protein interaction 
is another way by which the activity of c-di-GMP signaling 
proteins is regulated. In the Shewanella woodyi strain MS32, 
swDGC contains both diguanylate cyclase and phos-
phodiesterase domains. When bound by nitric oxide, 
H-NOX interacts with swDGC and increases its phos-
phodiesterase activity, thus influencing c-di-GMP metabo-
lism [24]. 
3  C-di-GMP effectors 
C-di-GMP has various downstream effectors including PilZ 
domain proteins [28], PelD of Pseudomonas aeruginosa 
[29], riboswitches [30], transcriptional factors [31,32], 
two-component histidine kinase [33], and polynucleotide 
phosphorylase [34]. C-di-GMP can also bind to the “I” site 
in the GGDEF domain of diguanylate cyclases [18] and 
degenerate GGDEF [35] and EAL [36] domains. These ef-
fectors include proteins, RNAs, enzymes and regulators. 
Bioinformatic analysis indicated that PilZ domain pro-
teins could be potential effectors of c-di-GMP [28]. Binding 
tests and mutation analyses of several PilZ proteins con-
firmed the prediction and identified RxxxR and D/NxSxxG 
as the sequence motifs required for c-di-GMP binding 
[37–40]. Additionally, recent studies have identified tran-
scriptional factors [31,32] and riboswitches [30] as 
c-di-GMP effectors. 
3.1  Transcriptional regulatory effectors 
Currently identified c-di-GMP transcriptional regulatory 
effectors include the sigma-54 dependent transcriptional 
regulator FleQ of P. aeruginosa [31], the transcriptional 
factor Clp of Xanthomonas axonopodis [41,42], the LuxR 
family transcriptional regulator VpsT of Vibrio cholerae 
[32], the CRP/FNR family transcriptional regulator 
Bcam1349 of Burkholderia cenocepacia [43] and a special 
activator MrkH found in Klebsiella pneumoniae [44]. 
FleQ of P. aeruginosa was the first identified c-di-GMP 
responsive transcriptional factor [31]. FleQ contains three 
domains including an N-terminal FleQ domain, a AAAσ54 
interaction domain and a C-terminal HTH domain. In vitro 
binding assays have shown that c-di-GMP can interact with 
the full length FleQ protein and its mutant fragnment that 
lack N-terminal FleQ domain. FleQ negatively regulates 
expression of genes involved in extracellular polysaccharide 
synthesis by binding to the pel operon. C-di-GMP binds to 
FleQ and inhibits the binding of FleQ to the pel operon, thus 
promoting expression of polysaccharide synthesis genes 
[31]. 
The global transcriptional regulator Clp controls the ex-
pression of a subset of virulence genes in X. campestris. 
This DNA-binding capability is abrogated by c-di-GMP, 
which binds to Clp with micromolar affinity [41,42]. 
VpsT of V. cholerae is a response regulator of typical 
two-component regulatory systems. However, two-compon- 
ent kinases that phosphorylate VpsT have not yet been iden-
tified. Early studies found that c-di-GMP affects regulation 
of VpsT but the mechanism was not clear. VpsT contains an 
N-terminal receiver domain and a C-terminal HTH domain. 
Recent studies have shown that two symmetrical c-di-GMP 
molecules form a dimer and interact with the receiver do-
main of VpsT. VpsT binds to c-di-GMP via a 4-residue mo-
tif W[F/L/M][T/S]R [32]. 
Bcam1349 of B. cenocepacia is a CRP/FNR family tran-
scriptional regulator that contains an N-terminal cyclic nu-
cleotide bound domain and a C-terminal HTH domain [43]. 
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C-di-GMP binds to full length Bcam1349 through its cyclic 
nucleotide bound domain. C-di-GMP promotes the binding 
of Bcam1349 to the promoter of the cellulose synthase gene 
[43]. 
C-di-GMP stimulates the promoter-binding activity of 
the transcriptional activator MrkH in K. pneumoniae [44]. 
MrkH binds strongly to the promoter of mrkA only in the 
presence of c-di-GMP. Notably, MrkH does not contain the 
typical HTH domain and thus represents a new class of 
c-di-GMP response regulators [44]. 
3.2  Riboswitch 
Riboswitch is a part of mRNA that regulates gene expres-
sion by binding to a small ligand molecule [45]. As PilZ 
domain proteins are absent in many species, it was initially 
assumed that riboswitches represent a new class of 
c-di-GMP receptors [2]. Subsequent studies confirmed this 
and identified two classes of riboswitches, Riboswitch-I [28] 
and Riboswitch-II [46], that bind c-di-GMP. Binding of 
c-di-GMP to Riboswitch-I could either activate or inhibit 
the expression of genes [28]. Structural analyses have indi-
cated that c-di-GMP binds to riboswitch-I in a symmetrical 
dimer form [47,48]. Riboswitch-II is known to associate 
with self-splicing ribozymes. C-di-GMP binding to Ri-
boswitch-II induces folding changes at atypical splice site 
junctions and modulation of RNA processing. Splice site 
variations can lead to changes in ribosomal binding sites 
and thus affect gene expression [46]. 
These studies clearly indicate that effectors of c-di-GMP 
are not limited to proteins but also include RNAs. Interest-
ingly, a recently study also found that c-di-GMP interacts 
with polynucleotide phosphorylase to regulate RNA pro-
cessing [34]. 
3.3  Two-component protein kinases  
Besides allosteric regulation of enzymes and DNA binding 
of transcriptional regulators, c-di-GMP also controls protein 
localization by direct interaction. The histidine kinase SgmT 
of Myxococcus xanthus is one of the newly identified 
c-di-GMP effectors [33]. C-di-GMP interacts with the 
GGDEF domain of SgmT which does not affect its auto-
phosphorylation and phosphate transfer activities. However, 
binding of c-di-GMP induces clustering of SgmT within the 
cell. SgmT mutation at the “I” site in the GGDEF domain 
leads to a more diffuse localization in the cell [33]. 
4  C-di-GMP and eukaryotes 
The currently known GGDEF, EAL and HD-GYP domain 
proteins that regulate c-di-GMP metabolism are ubiquitous  
in bacteria but absent in eukaryotes [13–15]. However, early 
studies found several proteins, such as plant cellulose syn-
thase [49] and human growth-promoting protein p21ras 
[8,50], that specifically bind to c-di-GMP with high affinity 
in both plants and animals. Recent studies indicate that 
c-di-GMP affects critical cellular processes including cellu-
lose synthesis [49], DNA synthesis [50], cell cycle [8] and 
cell proliferation [9] in eukaryotes. Interestingly, growing 
evidence indicates that c-di-GMP also interacts with the 
immune system of eukaryotes [10,51]. Exogenous applica-
tion of c-di-GMP induces expression of type I interferon [11] 
and can be directly sensed by the STING protein [52,53]. 
4.1  C-di-GMP affects cell cycle 
C-di-GMP has been shown to bind to and activate cellulose 
synthase in plants using labeled c-di-GMP as probe 
[1,54,55]. Several studies have also suggested a link be-
tween c-di-GMP and cell cycle-related processes in animal 
cells [8,9,50]. C-di-GMP irreversibly enhances DNA syn-
thesis but has no effect on cell replication in Molt4 cells 
[50]. In Jurkat cells, exogenous application of c-di-GMP 
induces blockage of cell cycle arrest at the S-phage and de-
crease in cell division [8]. C-di-GMP also inhibits basal and 
growth factor-stimulated human colon cancer cell prolifera-
tion [9]. C-di-GMP enters these cells and binds irreversibly 
to the growth-promoting protein p21ras [8,50]. It is possible 
that an irreversible binding of c-di-GMP to the p21ras pro-
tein results in a fixed active conformation of this protein, 
thereby affecting cell proliferation. 
4.2  C-di-GMP stimulate the immune system 
Several studies in rodents have shown that, owing to its 
interaction with the host immune system, c-di-GMP can 
produce antibacterial effects. C-di-GMP treatment reduces 
bacterial colonization by Staphylococcus aureus in a 
dose-dependent manner in a mouse model of mastitis infec-
tion. Interestingly, this effect is not mediated by inhibitory 
effects on S. aureus growth by c-di-GMP [56]. It has thus 
been proposed that the antibacterial effects come from the 
effect of c-di-GMP on the host immune system. By per-
forming a systematical analysis of the response of the im-
mune system to c-di-GMP, Karaolis confirmed that 
c-di-GMP is indeed an immunostimulatory molecule that 
induces a wide range of response pathways of the immune 
system [10]. Consistent with studies in S. aureus (a 
gram-positive pathogen), c-di-GMP also induces a signifi-
cant protective immune response and improved bacteria 
clearance against a virulent strain of K. pneumoniae (a 
gram-negative pathogen) in a mouse model of bacterial 
penumonia [51].  
Further studies exploring the mechanisms underlying the 
above observation indicate that c-di-GMP is sensed by a 
novel cytosolic immunosurveillance pathway. Responsive-
ness of c-di-GMP is independent of TLRs which monitor 
the signal stimulation. The transcriptional profile of host 
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cells provoked by c-di-GMP is similar to that which are 
triggered by extracellular DNA or RNA [11]. However, 
several known nucleic acid-sensing pathways are not re-
quired for responses to c-di-GMP, which suggests that there 
must be at least one additional nucleic acid sensor in the 
cytosol that responds well to c-di-GMP. Recent studies have 
found that STING is required for type I interferon to re-
spond to c-di-GMP [52] and STING is a direct innate im-
mune sensor of c-di-GMP [53]. These studies have provided 
valuable insights into the fundamental mechanisms by 
which the innate immune system responds to c-di-GMP.  
5  C-di-GMP signaling in M. tuberculosis 
5.1  Current progress 
Two c-di-GMP signaling proteins Rv1354c and Rv1357c 
have been identified based on domain analysis in M. tuber-
culosis. Rv1354c contains three domains (GAF-GGEDF- 
EAL) while Rv1357c contains a single domain (EAL) (Fig-
ure 3). The “GGDEF” (residues 261–265 in Rv1354c) and 
“EAL” (residues 389–391 in Rv1354c, residues 89–91 in 
Rv1357c) amino acid residues are well-conserved in both 
proteins. In addition, the full length amino acid sequence 
and gene location are also well-conserved across the H37Rv, 
H37Ra and BCG strains except for a single mutation in the 
Rv1357c homolog in the BCG strain. Furthermore, the 
c-di-GMP metabolism activity of Rv1354c and Rv1357c 
has been validated in vitro [57]. 
Rv1354c has been found to be completely disrupted in 
clinical isolates of the M. tuberculosis Haarlem strain, 
which indicates that Rv1354c is not essential for survival 
and infectivity of M. tuberculosis [58]. However, disruption 
of Rv1357c by transposon insertion has been found to cause 
attenuation of BCG infection of macrophages, which re-
flects a link between c-di-GMP signaling and infectivity of 
M. tuberculosis [59]. Another gene expression analysis 
found that expression of both Rv1354c and Rv1354c was 
increased during infection of macrophages and reduced in 
H2O2-treated M. tuberculosis [60]. This suggests that 
c-di-GMP signaling plays as yet unknown roles in M. tu-
berculosis. Our current knowledge about c-di-GMP signal-
ing in M. tuberculosis is still limited compared to that    
in other pathogens like V. cholerae, P. aeruginosa and    
S. typhi. 
5.2  Potential roles of c-di-GMP in M. tuberculosis 
Full length Rv1354c contains an N-terminal signal sensory  
 
 
Figure 3  Domain of c-di-GMP signaling proteins Rv1354c and Rv1354c 
in M. tuberculosis. 
GAF domain, and two domains—GGDEF and EAL—that 
have opposite enzymatic activities. The domain composi-
tion of Rv1354c shows a switch structure which implies that 
the GAF domain senses environmental signal and regulates 
the enzyme activities of GGDEF and EAL domains. A pos-
sible model of Rv1354c activation could be similar to that 
known for PleD [18]: when Rv1354c is stimulated by a 
signalling molecule or is phosphorylated, it may form di-
mers that exhibit diguanylate cyclase activity. However, 
when the environmental signal changes or when the protein 
is dephosphorylated, it may work as a monomer and exhibit 
phosphodiesterase activity.  
The sensory domain of a signaling protein can provide 
important clues for inferring its potential roles. The GAF 
domain is a ubiquitous signal sensory domain in both pro-
karyotes and eukaryotes [61]. It has been shown that the 
GAF domain can sense cGMP and cAMP [61]. A recent 
study has shown that c-di-GMP senses MetO as an indicator 
of oxidation and nutrition stress [62]. In addition, the GAF 
domain can sense NO [63]. It is worth noting that NO has 
been found to induce antimicrobial activity by affecting the 
eukaryotic host immune system as well as dormant M. tu-
berculosis [64,65]. Taken together, these studies show that 
the GAF domain is bound by a diverse set of ligands that 
includes signalling molecules that mediate both important 
host signaling and stress response in bacteria. Therefore, 
GAF domain-containing proteins such as Rv1354c may 
play important roles in stress response and pathogen-host 
interaction in bacteria. Interestingly, two other GAF do-
main-containing proteins, the two-component signal sensory 
histidine kinase DosT (Rv332c) and DosS (Rv2027c), have 
been shown to participate in regulating dormancy in M. tu-
berculosis [66,67]. Furthermore, MSMEG_2196, the 
Rv1354c homolog in M. smegmatis, has been shown to be 
critical for long-term survival of the bacteria under condi-
tions of nutrition stress [68]. 
Analysis of the subcellular localization of Rv1354 in M. 
tuberculosis has revealed that it is an inner membrane 
protein [69]. Since a typical transmembrane region was not 
identified in Rv1354c using several bioinformatic tools, it 
is likely that Rv1354c physically associates with other 
membrane proteins. In our previous study, we predicted 
and validated interaction between Rv1354c and a group of 
ABC transporters [26]. Although this interaction may ex-
plain the membrane localization of Rv1354c, the cellular 
role of the interaction is still unclear. Considering that 
c-di-GMP regulates polysaccharides and colony morphol-
ogy in several other bacteria, one possibility is that 
Rv1354c affects the extracellular matrix of M. tuberculosis 
by regulating the transport activity of the ABC transporters. 
In addition, since c-di-GMP has been shown to interact 
with the host immune system [10,11], the interaction of 
Rv1354c with ABC transporters may facilitate c-di-GMP 
to transport across the membrane if it is secreted by M. 
tuberculosis. 
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Figure 4  C-di-GMP signaling system. 
6  Conclusions  
C-di-GMP is a ubiquitous bacterial second messenger that 
regulates a wide range of cellular processes such as biofilm 
formation, virulence, motility and differentiation. Its func-
tional diversity can be attributed to its diverse upstream 
ligands and downstream effectors. This review summarizes 
our recent understanding on c-di-GMP signaling (Figure 4). 
After the initial discovery of PilZ domain proteins as 
their effectors, several transcriptional regulators and ri-
boswitches were identified as c-di-GMP effectors. In addi-
tion, histidine kinase and polynucleotide phosphorylase 
have recently been identified as c-di-GMP effectors. These 
new findings indicate that c-di-GMP can affect cellular 
processes by several mechanisms including regulation of 
enzyme activity, gene expression and subcellular localiza-
tion of other proteins (Figure 4). However, a general mech-
anism of effector recognition by c-di-GMP is still absent, 
which has limited identification of new effectors using bio-
informatic methods. Although great strides in effector iden-
tification has been made, potential new types of effectors 
may exist considering that homologs of currently known 
effectors are absent in some species that employ c-di-GMP 
signaling.  
Genomics, biochemistry and gene expression profiling 
approaches have revealed that c-di-GMP signaling is active 
in M. tuberculosis. However, our understanding of the 
downstream effectors of c-di-GMP and their physiological 
roles is still largely limited. Neither PilZ domain proteins 
nor other proteins that are homologous to current known 
effectors have been identified yet in M. tuberculosis. Alt-
hough these areas need further research, bioinformatic 
analyses suggest that c-di-GMP may play important roles in 
regulation of dormancy and host interaction in M. tubercu-
losis. 
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